Healio has taken a major step in advancing its digital transformation by naming Joan-Marie Stiglich as the company’s first Chief AI Officer, a newly established executive position that underscores Healio’s commitment to expanding the role of artificial intelligence across its healthcare publishing and clinical information platforms.
The appointment places Stiglich at the center of Healio’s next phase of innovation. In her new role, she will lead the strategic development, implementation, and governance of Healio AI, guiding how emerging technologies are used to improve medical education, streamline clinical workflows, and enhance the delivery of trusted health information to physicians and care teams nationwide.
Healio, a division of the Wyanoke Group, has become a widely used resource among healthcare professionals seeking up-to-date, peer-reviewed medical content. By formally elevating AI leadership to the executive level, the organization is signaling that artificial intelligence will play a foundational role in how medical knowledge is curated, verified, and distributed in the years ahead.
Stiglich brings extensive experience in medical publishing, editorial standards, and digital innovation. She has built a reputation for blending rigorous clinical accuracy with emerging technology, making her well-positioned to guide responsible AI deployment in healthcare communications. Her leadership will focus on expanding AI-powered tools that support physicians in accessing clinical insights more efficiently while maintaining the integrity, transparency, and evidence-based standards that define Healio’s brand.
The creation of the Chief AI Officer role reflects broader trends reshaping healthcare information systems. As artificial intelligence becomes more deeply embedded in diagnostics, patient engagement, and clinical decision-support tools, publishers and data platforms are increasingly tasked with ensuring that AI applications remain accurate, ethical, and compliant with evolving regulatory expectations.
Under Stiglich’s direction, Healio AI is expected to expand in scope, with initiatives aimed at personalizing content delivery, accelerating medical research discovery, and improving how clinicians navigate large volumes of peer-reviewed data. These advancements are designed to help healthcare providers make faster, more informed decisions while reducing administrative burdens that can impact patient care.
Industry observers view Healio’s move as a proactive investment in the future of healthcare publishing. By establishing executive oversight for artificial intelligence, the company is positioning itself at the forefront of medical media innovation, reinforcing its ability to adapt to the rapidly changing digital healthcare ecosystem.
Readers interested in developments shaping healthcare technology, digital publishing, and artificial intelligence across the business sector can find ongoing coverage in Sunset Daily’s Technology & Tech section, which tracks emerging platforms, leadership changes, and innovation trends influencing New Jersey and beyond.
Healio’s strategic expansion of its AI leadership infrastructure highlights a growing recognition that intelligent systems are no longer supplemental tools but central components of modern healthcare information delivery. With Stiglich guiding this transformation, the company is setting a clear course toward a more responsive, data-driven future in medical publishing.
